Ewelina Kluza

1.8k citations
16 papers · 644 indexed · h-index 11

Ewelina Kluza

16 papers receiving 634 citations

Peers

Ewelina Kluza
Comparison fields: 5 of 83
  • Biomaterials 231
  • Immunology and Allergy 39
  • Radiology, Nuclear Medicine and Imaging 130
  • Immunology 108
  • Biomedical Engineering 221
Replace Kathryn C. Partlow with:
Kathryn C. Partlow United States
Khalid Abu Ajaj Germany
Yue Geng United States
Giulia Pellizzari United Kingdom
Yesen Li China
Lingyi Sun China
Melissa M. Sprachman United States
Birgit Blechert Germany
Micah John Luderer United States
Gail Rowlinson‐Busza United Kingdom
Ewelina Kluza relative to Kathryn C. Partlow United States Kathryn C. Partlow's profile →
Citations per field
00.5×
Kathryn C. Partlow · 1×
Citations per year

Countries citing papers authored by Ewelina Kluza

Since Specialization
Citations

This map shows the geographic impact of Ewelina Kluza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewelina Kluza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewelina Kluza more than expected).

Fields of papers citing papers by Ewelina Kluza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewelina Kluza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewelina Kluza. The network helps show where Ewelina Kluza may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ewelina Kluza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ewelina Kluza Line = papers co-authored together Ewelina Kluza links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20256
2 202354
3 20219
4 202111
5 202056
6 201984
7 20158
8 201450
9 20145
10 201237
11 20124
12 201112
13 201166
14 201045
15 201074
16 2009123

About Ewelina Kluza

Ewelina Kluza is a scholar working on Immunology and Allergy, Immunology and Biomaterials, having authored 16 papers that have together received 644 indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (4 papers), Nanoparticle-Based Drug Delivery (4 papers), MRI in cancer diagnosis (4 papers), Cell Adhesion Molecules Research (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biomaterials (231 citations), Immunology and Allergy (39 citations) and Radiology, Nuclear Medicine and Imaging (130 citations). Ewelina Kluza has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Klaas Nicolay, Gustav J. Strijkers, Willem J. M. Mulder, Arjan W. Griffioen, Daisy W.J. van der Schaft, Kevin H. Mayo, Petra Hautvast, Roy van der Meel, Abraham J. P. Teunissen and Geerard L. Beets. Their work appears in journals such as Nano Letters, ACS Nano and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026